Indivior PLC (NASDAQ:INDV) Short Interest Update

Indivior PLC (NASDAQ:INDV) saw a significant growth in short interest in April. As of April 15th, there was short interest totalling 201,800 shares, a growth of 15.8% from the March 31st total of 174,300 shares. Based on an average daily trading volume, of 129,300 shares, the short-interest ratio is currently 1.6 days. Currently, 0.2% of the shares of the company are short sold.

Analyst Upgrades and Downgrades

Separately, Craig Hallum initiated coverage on Indivior in a report on Wednesday, April 3rd. They issued a “buy” rating and a $37.00 price objective on the stock.

Hedge Funds Weigh In On Indivior

Several institutional investors and hedge funds have recently bought and sold shares of the company. Campbell & CO Investment Adviser LLC grew its position in Indivior by 2.8% in the fourth quarter. Campbell & CO Investment Adviser LLC now owns 37,948 shares of the company’s stock worth $573,000 after acquiring an additional 1,037 shares during the period. Mackenzie Financial Corp raised its holdings in Indivior by 0.3% in the 3rd quarter. Mackenzie Financial Corp now owns 562,595 shares of the company’s stock valued at $12,979,000 after buying an additional 1,909 shares during the period. Renaissance Group LLC lifted its position in Indivior by 2.1% in the third quarter. Renaissance Group LLC now owns 97,127 shares of the company’s stock valued at $2,241,000 after buying an additional 1,959 shares during the last quarter. Swiss National Bank lifted its position in Indivior by 1.0% in the third quarter. Swiss National Bank now owns 287,897 shares of the company’s stock valued at $6,257,000 after buying an additional 2,727 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Indivior by 15.7% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 39,596 shares of the company’s stock worth $860,000 after buying an additional 5,365 shares during the period. 60.33% of the stock is currently owned by institutional investors and hedge funds.

Indivior Trading Down 2.1 %

Shares of INDV stock opened at $17.56 on Wednesday. Indivior has a fifty-two week low of $14.38 and a fifty-two week high of $26.50. The firm has a market capitalization of $2.42 billion, a P/E ratio of 1,756.00 and a beta of 0.46. The stock’s fifty day moving average is $20.51 and its two-hundred day moving average is $18.26. The company has a debt-to-equity ratio of 23.50, a quick ratio of 0.74 and a current ratio of 0.92.

Indivior (NASDAQ:INDV) last posted its quarterly earnings results on Thursday, February 22nd. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.15. The business had revenue of $293.00 million during the quarter, compared to analyst estimates of $260.00 million. Indivior had a return on equity of 842.72% and a net margin of 0.44%. Research analysts expect that Indivior will post 2 earnings per share for the current fiscal year.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.